$CETI
Cyber Enviro-Tech, Inc. Stock $ceti

$ceti Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000107997323001178 Filed on August 18, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$13.90K	$0.00
YoY Change	-76.07%
Cost Of Revenue	$3.709K	$0.00
YoY Change	-74.96%
Gross Profit	$10.19K	$0.00
YoY Change	-76.45%
Gross Profit Margin	73.31%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.65K	$12.65K	$10.91K
YoY Change	-0.21%	15.89%
% of Gross Profit	124.13%
Operating Expenses	$748.0K	$878.4K	$144.4K
YoY Change	537.11%	508.44%
Operating Profit	-$737.9K	-$878.4K	-$144.4K
YoY Change	898.61%	508.44%
Interest Expense	$146.9K	$47.95K	$12.18K
YoY Change	-9.5%	293.61%
% of Operating Profit
Other Income/Expense, Net	-$108.2K	-$69.58K	-$9.647K
YoY Change	-33.35%	621.23%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$846.0K	-$947.9K	-$154.0K
YoY Change	258.22%	515.39%
Net Earnings / Revenue	-6087.85%
Basic Earnings Per Share	-$0.01	-$0.01	$0.00
Diluted Earnings Per Share	-$0.01	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	118.2M shares	116.3M shares	107.4M shares
Diluted Shares Outstanding	120.5M shares	116.5M shares	107.4M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$539.2K	$148.1K	$136.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$765.9K	$328.1K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$3.331M	$3.167M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.120M	$3.963M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$765.9K	$328.1K
Total Long-Term Assets	$4.120M	$3.963M
Total Assets	$4.886M	$4.291M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$122.2K	$86.20K
YoY Change
Accrued Expenses	$47.11K	$19.39K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$2.500M	$2.059M
YoY Change
Long-Term Debt Due	$366.0K	$489.7K
YoY Change
Total Short-Term Liabilities	$617.3K	$600.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$617.3K	$600.0K
Total Long-Term Liabilities
Total Liabilities	$2.786M	$2.272M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$4.731M	-$3.885M
YoY Change
Common Stock	$121.3K	$118.2K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$66.40K	$66.40K
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.100M	$2.020M	$1.432M
YoY Change
Total Liabilities & Shareholders Equity	$4.886M	$4.291M
YoY Change

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$846.0K	-$947.9K	-$154.0K
YoY Change	258.22%	515.39%
Depreciation, Depletion And Amortization	$12.65K	$12.65K	$10.91K
YoY Change	-0.21%	15.89%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001935092
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue		usd
CY2023Q2	CETI	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent		usd
CY2022Q4	CETI	Convertible Note Payable Current ConvertibleNotePayableCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	CETI	Common Stock To Be Issued CommonStockToBeIssued		usd
CY2022Q2	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives		usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2022Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2023Q2	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2022Q2	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2022Q2	CETI	Book Adjustments Rounding And Fractional Shs BookAdjustmentsRoundingAndFractionalShs		usd
CY2022Q2	CETI	Common Stock Issued From Prior Periods CommonStockIssuedFromPriorPeriods		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q2	CETI	Shares Issued For Conversion Of Advance On Joint Venture SharesIssuedForConversionOfAdvanceOnJointVenture		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	CETI	Common Stock Issued From Prior Periods CommonStockIssuedFromPriorPeriods		usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	CETI	Shares Issued For Conversion Of Advance On Joint Venture SharesIssuedForConversionOfAdvanceOnJointVenture		usd
CY2023Q1	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable		usd
CY2023Q2	CETI	Common Stock Issued From Prior Periods CommonStockIssuedFromPriorPeriods		usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q2	CETI	Shares Issued For Conversion Of Advance On Joint Venture SharesIssuedForConversionOfAdvanceOnJointVenture		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	CETI	Acquisition Of Licenses From Kam Biotechnology Ltd AcquisitionOfLicensesFromKamBiotechnologyLtd		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	CETI	Repayment Of Notes Payable Related Party RepaymentOfNotesPayableRelatedParty		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	CETI	Stock Issued For Conversion Of Advance On Joint Venture StockIssuedForConversionOfAdvanceOnJointVenture		usd
	CETI	Note Payable Conversion NotePayableConversion		usd
	CETI	Convertible Note Payable Converted ConvertibleNotePayableConverted		usd
	CETI	Stock Issued For Conversion Of Convertible Notes Payable And Accrued Interest StockIssuedForConversionOfConvertibleNotesPayableAndAccruedInterest		usd
CY2022Q2	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives		usd
CY2023Q2	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative		usd
CY2022Q2	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative		usd
CY2022Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet		usd
	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives		usd
	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative		usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet		usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2022	CETI	Changes In Fair Value Inputs And Assumptions Reflected In Income ChangesInFairValueInputsAndAssumptionsReflectedInIncome		usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-267560
	dei	Entity Registrant Name EntityRegistrantName	Cyber Enviro-Tech, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3601702
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6991 E. Camelback Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite D-300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Scottsdale
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85251
	dei	City Area Code CityAreaCode	(307)
	dei	Local Phone Number LocalPhoneNumber	200-2803
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	118239283	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	148058	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	297349	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	179999	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9537	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	328057	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	392820	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3167312	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2429035	usd
CY2023Q2	CETI	Texas Railroad Commission Bond TexasRailroadCommissionBond	50000	usd
CY2022Q4	CETI	Texas Railroad Commission Bond TexasRailroadCommissionBond	50000	usd
CY2023Q2	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue	745859	usd
CY2023Q2	us-gaap	Assets Assets	4291228	usd
CY2022Q4	us-gaap	Assets Assets	2871855	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	86202	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	149835	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19389	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7489	usd
CY2023Q2	CETI	Contingent Liability ContingentLiability	4650	usd
CY2022Q4	CETI	Contingent Liability ContingentLiability	5700	usd
CY2022Q4	CETI	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	15000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	10441	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	19887	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	433059	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	237613	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	37576	usd
CY2023Q2	CETI	Convertible Note Payable Current ConvertibleNotePayableCurrent	31674	usd
CY2023Q2	CETI	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	25000	usd
CY2022Q4	CETI	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	25000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	599974	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	440637	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	37727	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	1645	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	99162	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	184355	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	102466	usd
CY2023Q2	CETI	Convertible Long Term Note Payable ConvertibleLongTermNotePayable	1470000	usd
CY2022Q4	CETI	Convertible Long Term Note Payable ConvertibleLongTermNotePayable	386000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2271602	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1010992	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	118239283	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	118239283	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	115914283	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	115914283	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	118240	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	115915	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5254706	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4368442	usd
CY2023Q2	CETI	Common Stock To Be Issued CommonStockToBeIssued	1283636	usd
CY2023Q2	CETI	Unearned Stock Compensation UnearnedStockCompensation	685711	usd
CY2022Q4	CETI	Unearned Stock Compensation UnearnedStockCompensation	124274	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	66400	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	66400	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3884845	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2432820	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2019626	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1860863	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4291228	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2871855	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	20253	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	10000	usd
	us-gaap	Professional Fees ProfessionalFees	65288	usd
	us-gaap	Professional Fees ProfessionalFees	29175	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	89408	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25152	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	131111	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	54983	usd
CY2023Q2	CETI	Consulting Expense ConsultingExpense	768701	usd
CY2022Q2	CETI	Consulting Expense ConsultingExpense	109211	usd
	CETI	Consulting Expense ConsultingExpense	1136514	usd
	CETI	Consulting Expense ConsultingExpense	156312	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	878365	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	144363	usd
	us-gaap	Operating Expenses OperatingExpenses	1332913	usd
	us-gaap	Operating Expenses OperatingExpenses	240470	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-878365	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-144363	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1332913	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-240470	usd
CY2023Q2	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	-22977	usd
	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	49392	usd
	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	2638153	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-86858	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-149010	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-3600	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	627591	usd
CY2023Q2	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	-1350	usd
CY2022Q2	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	-2535	usd
	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	-1050	usd
	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	3031	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	47950	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	12182	usd
	us-gaap	Interest Expense InterestExpense	79096	usd
	us-gaap	Interest Expense InterestExpense	1224495	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-69577	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9647	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-119112	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1889208	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-947942	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-154040	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1452025	usd
	us-gaap	Net Income Loss NetIncomeLoss	1648738	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	116526714	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	116526714	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107444943	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107444943	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	115943449	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115943449	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106954123	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106954123	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2578885	usd
CY2022Q1	CETI	Common Stock Issued From Prior Periods CommonStockIssuedFromPriorPeriods	-0	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100000	usd
CY2022Q1	CETI	Shares Issued For Conversion Of Advance On Joint Venture SharesIssuedForConversionOfAdvanceOnJointVenture	233983	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	9999	usd
CY2022Q1	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable	75800	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1853196	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1779378	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1473470	usd
CY2022Q2	CETI	Options Granted For Services OptionsGrantedForServices	4843	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11550	usd
CY2022Q2	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable	95699	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-154040	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1431522	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1860863	usd
CY2023Q1	CETI	Options Granted For Services OptionsGrantedForServices	5514	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	256384	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	60000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-504083	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1678678	usd
CY2023Q2	CETI	Options Granted For Services OptionsGrantedForServices	5575	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	619679	usd
CY2023Q2	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable	663636	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-947942	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2019626	usd
	us-gaap	Profit Loss ProfitLoss	-1452025	usd
	us-gaap	Profit Loss ProfitLoss	1648738	usd
	CETI	Changes In Fair Value Of Derivatives ChangesInFairValueOfDerivatives	102466	usd
	CETI	Changes In Fair Value Of Derivatives ChangesInFairValueOfDerivatives	-2638153	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3100	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-149010	usd
	CETI	Options Issued For Services OptionsIssuedForServices	11089	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	627591	usd
	CETI	Changes In Fair Value Of Contingent Liability ChangesInFairValueOfContingentLiability	-1050	usd
	CETI	Changes In Fair Value Of Contingent Liability ChangesInFairValueOfContingentLiability	3031	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	876063	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6794	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	38515	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1198099	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	38394	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18228	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	84528	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	32796	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-63633	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	95719	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	28536	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	26394	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-503073	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-152527	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13600	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	780729	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	905276	usd
	CETI	Acquisition Of Licenses From Kam Biotechnology Ltd AcquisitionOfLicensesFromKamBiotechnologyLtd	659339	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1426468	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-905276	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	311000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2056250	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	775000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	100000	usd
	CETI	Repayment Of Notes Payable Related Party RepaymentOfNotesPayableRelatedParty	65000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1780250	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	875000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-149291	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-182803	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	297349	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	318779	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148058	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	135976	usd
	CETI	Stock Issued For Conversion Of Advance On Joint Venture StockIssuedForConversionOfAdvanceOnJointVenture	233983	usd
	CETI	Note Payable Conversion NotePayableConversion	20000	usd
	CETI	Convertible Note Payable Converted ConvertibleNotePayableConverted	6636	usd
	CETI	Stock Issued For Conversion Of Convertible Notes Payable And Accrued Interest StockIssuedForConversionOfConvertibleNotesPayableAndAccruedInterest	2011065	usd
CY2023Q2	CETI	Contingent Liability ContingentLiability	4650	usd
CY2022Q4	CETI	Contingent Liability ContingentLiability	5700	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zKa2Mecmebsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_863_zOXYVwoDnoK1">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"> </p>
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	489734	usd
CY2023Q2	us-gaap	Cash Cash	0	usd
CY2022Q4	us-gaap	Cash Cash	0	usd
CY2023Q2	CETI	Texas Railroad Commission Bond TexasRailroadCommissionBond	50000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	277613	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	1569161	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	570355	usd
CY2023Q2	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue	12642	usd
CY2023Q2	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue	745859	usd
CY2023Q2	us-gaap	Other Notes Payable OtherNotesPayable	663111	usd
CY2023Q2	us-gaap	Production Costs Cumulative ProductionCostsCumulative	2187926	usd
CY2022Q4	us-gaap	Production Costs Cumulative ProductionCostsCumulative	1604983	usd
	us-gaap	Impairment Of Oil And Gas Properties ImpairmentOfOilAndGasProperties	0	usd
	us-gaap	Impairment Of Oil And Gas Properties ImpairmentOfOilAndGasProperties	0	usd
	us-gaap	Gain Loss On Sale Of Unproved Property GainLossOnSaleOfUnprovedProperty	0	usd
	us-gaap	Gain Loss On Sale Of Unproved Property GainLossOnSaleOfUnprovedProperty	0	usd
CY2023Q2	us-gaap	Development Costs Cumulative DevelopmentCostsCumulative	0	usd
CY2022Q4	us-gaap	Development Costs Cumulative DevelopmentCostsCumulative	0	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	0	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	0	usd
	CETI	Impairment Proved Properties ImpairmentProvedProperties	0	usd
	CETI	Impairment Proved Properties ImpairmentProvedProperties	0	usd
CY2023Q2	CETI	Unearned Stocks Compensation UnearnedStocksCompensation	685711	usd
CY2022Q4	CETI	Unearned Stocks Compensation UnearnedStocksCompensation	124274	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	102466	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	102466	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zDerNqJHI2N8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_861_zpBuw7R2Qj84">Concentration of credit risks</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains accounts with financial institutions. All cash in checking accounts is non-interest bearing and is fully secured by the Federal Deposit Insurance Corporation (FDIC). At times, cash balances may exceed the maximum coverage provided by the FDIC on insured depositor accounts. The Company believes it mitigates its risk by depositing its cash and cash equivalents with major financial institutions.</p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"> </p>
CY2021Q1	CETI	Working Interest WorkingInterest	0.1875	pure
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	74301	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58224	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3167312	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2429035	usd
CY2023Q2	us-gaap	Depreciation Depreciation	12646	usd
CY2022Q2	us-gaap	Depreciation Depreciation	10912	usd
	us-gaap	Depreciation Depreciation	25752	usd
	us-gaap	Depreciation Depreciation	10912	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	2144639	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	869500	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	85743	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	21532	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	2058895	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	847968	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	282500	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	255250	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1606889	usd
CY2023Q2	us-gaap	Other Long Term Debt OtherLongTermDebt	2144639	usd
CY2023Q2	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives	-22977	usd
CY2023Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-22977	usd
	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives	49392	usd
	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative	86858	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-37466	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0072
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.3100
CY2022	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.0024
	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.2015
CY2022	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P1Y
	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P0Y6M29D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.5108	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.7120	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.6878	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.9781	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0479	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.1390	pure
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	3116734	usd
	CETI	Issuance Of Embedded Derivatives IssuanceOfEmbeddedDerivatives	151858	usd
CY2022	CETI	Issuance Of Embedded Derivatives IssuanceOfEmbeddedDerivatives	396013	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3512747	usd
	CETI	Changes In Fair Value Inputs And Assumptions Reflected In Income ChangesInFairValueInputsAndAssumptionsReflectedInIncome	-49392	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	102466	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	CETI	Consulting Service ConsultingService	284500	usd
CY2022	CETI	Consulting Service ConsultingService	431399	usd
	CETI	Consulting Fees ConsultingFees	60188	usd
CY2022	CETI	Consulting Fees ConsultingFees	194712	usd
CY2023Q2	CETI	Quoted Market Price QuotedMarketPrice	0.782
CY2023Q2	us-gaap	Share Price SharePrice	0.5765
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	297278	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	307643	usd
	CETI	Less Valuation Allowance LessValuationAllowance	297278	usd
	CETI	Less Valuation Allowance LessValuationAllowance	307643	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	807711	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	510433	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	807711	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	510433	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	807711	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	CETI	Average Sales Price AverageSalesPrice	70.64
CY2022	CETI	Average Sales Price AverageSalesPrice	94.13
	CETI	Average Sales Price AverageSalesPrice	70.64
	CETI	Recoverable Oil Price RecoverableOilPrice	3200000000	usd
	us-gaap	Production Costs ProductionCosts	1000000000.0	usd
	CETI	Recoverable Oil Price Net RecoverableOilPriceNet	2200000000	usd

Files In Submission

Name	View Source	Status
0001079973-23-001178-index-headers.html	Edgar Link	pending
0001079973-23-001178-index.html	Edgar Link	pending
0001079973-23-001178.txt	Edgar Link	pending
0001079973-23-001178-xbrl.zip	Edgar Link	pending
ceti-20230630.xsd	Edgar Link	pending
cyber_10q-063023.htm	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
ceti-20230630_def.xml	Edgar Link	unprocessable
ceti-20230630_lab.xml	Edgar Link	unprocessable
ceti-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cyber_10q-063023_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ceti-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CETI
Cyber Enviro-Tech, Inc. Stock $ceti

2023 Q3 Form 10-Q Financial Statement

#000107997323001178 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CETI Cyber Enviro-Tech, Inc. Stock $ceti

2023 Q3 Form 10-Q Financial Statement

#000107997323001178 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CETI
Cyber Enviro-Tech, Inc. Stock $ceti